Pharmacogenomics in the UK National Health Service: Progress towards implementation

McDermott, John H, Tsakiroglou, Maria ORCID: 0000-0001-7946-3953, Newman, William G and Pirmohamed, Munir ORCID: 0000-0002-7534-7266 (2025) Pharmacogenomics in the UK National Health Service: Progress towards implementation BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 91 (8). pp. 2241-2250. ISSN 0306-5251, 1365-2125

Access the full-text of this item by clicking on the Open Access link.

Abstract

Over the past decade there has been considerable and growing enthusiasm about the promise of using genomics to inform healthcare. In particular, using genetic data to inform prescribing practice has emerged as a compelling policy priority for health systems around the world, not least in the NHS. Various initiatives and strategies have been developed to explore the value of pharmacogenomics in the UK National Health Service (NHS) and identify strategies for implementation. The NHS England Network of Excellence for Pharmacogenomics and Medicines Optimisation (PGx-NoE) was launched in 2024 and held two stakeholder meetings over the year in collaboration with the UK Pharmacogenetics and Stratified Medicine Network and the British Pharmacological Society (BPS). This article describes the outputs of those meetings, which are discussed in the context of previously identified challenges and opportunities. Rather than simply identify further barriers or facilitators, outputs are contextualized around tangible recommendations and real-world implementation exercises. These are grouped into three key areas: genetics, data and service. The work of partners across the UK are highlighted, including development of the NHS England Genomic Test Directory, the proof-of-principle informatic patterns demonstrated by the PROGRESS study, and the launch of the Centre for Excellence in Regulatory Science and Innovation (CERSI) in Pharmacogenomics, which will create UK-specific guidance and clarify complex regulatory pathways. Many of the well-defined barriers to the implementation of pharmacogenomics have been addressed in recent years, and this work highlights how the UK has the opportunity to emerge as a global leader in genomics-informed healthcare.

Item Type:	Article
Uncontrolled Keywords:	clinical pharmacology, genetics and pharmacogenetics, medication safety, pharmacogenomics
Divisions:	Faculty of Health & Life Sciences Faculty of Health & Life Sciences > Inst. Systems, Molec & Integrative Biology > Inst. Systems, Molec & Integrative Biology
Depositing User:	Symplectic Admin
Date Deposited:	13 Jun 2025 08:13
Last Modified:	16 Jun 2026 20:07
DOI:	10.1002/bcp.70109
Open Access URL:	Pharmacogenomics in the UK National Health Service...
Related Websites:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3193212
Disclaimer:	The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.